Medifast, Inc. (MDF.F)
| Previous Close | 30.47 |
| Open | 31.27 |
| Bid | 31.05 x 10700 |
| Ask | 31.80 x 10300 |
| Day's Range | 31.27 - 31.27 |
| 52 Week Range | 29.07 - 98.00 |
| Volume | |
| Avg. Volume | 13 |
| Market Cap | 350.111M |
| Beta (5Y Monthly) | 1.15 |
| PE Ratio (TTM) | 3.68 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 6.16 (20.21%) |
| Ex-Dividend Date | Sept 18, 2023 |
| 1y Target Est | N/A |
- Business Wire
Medifast to Announce Financial Results for the First Quarter Ended March 31, 2024
BALTIMORE, April 15, 2024--Medifast (NYSE: MED), the health and wellness company known for its habit-based and Coach-guided lifestyle solution, OPTAVIA®, will announce financial results for the first quarter ended March 31, 2024 on Monday, April 29, 2024, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, and Jim Maloney, Chief Financial Officer.
- Business Wire
Medifast Announces Fourth Quarter and Full Year 2023 Financial Results
BALTIMORE, February 20, 2024--Medifast (NYSE: MED), the health and wellness company known for its habit-based and Coach-guided lifestyle solution, OPTAVIA®, today reported results for the fourth quarter and full year ended December 31, 2023.
- Business Wire
Medifast to Announce Financial Results for the Fourth Quarter and Full Year Ended December 31, 2023
BALTIMORE, February 06, 2024--Medifast (NYSE: MED), the health and wellness company known for its habit-based and Coach-guided lifestyle solution, OPTAVIA®, will announce financial results for the fourth quarter and full year ended December 31, 2023 on Tuesday, February 20, 2024, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, and Jim Maloney, Chi
